Table 2.
PLN |
Tumor size |
Total | ||||
---|---|---|---|---|---|---|
First site of failure | Negative | Positive | ≤ Median | > Median | 36 | |
SqCC | Locoregional failure | 5 (27.8%) | 4 (22.2%) | 4 (22.2%) | 5 (27.8%) | 9 (25.0%) |
Distant failure | 2 (11.1%) | 11 (61.1%) | 6 (33.3%) | 7 (38.9%) | 13 (36.1%) | |
PALN failure | 1 (5.5%) | 8 (44.4%) | 4 (22.2%) | 5 (27.8%) | 9 (25.0%) | |
Total | 18 | 18 | 18 | 18 | 36 | |
AC | Locoregional failure | 7 (22.6%) | 11 (45.8%) | 7 (25.0%) | 11 (37.9%) | 18 (32.7%) |
Distant failure | 14 (45.2%) | 13 (54.2%) | 11 (39.3%) | 16 (59.3%) | 27 (49.1%) | |
PALN failure | 2 (6.5%) | 8 (33.3%) | 4 (14.3%) | 6 (22.2%) | 10 (18.2%) | |
Total | 31 | 24 | 27 | 28 | 55 |